JIM
MRNA icon

Jupiter Investment Management’s Moderna MRNA Stock Holding History

Jupiter Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$970K Buy
+15,108
New +$827K 0.02% 288

Other funds holding MRNA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Jupiter Investment Management's MRNA Position: Q2 2020 in Review

Jupiter Investment Management opened a new position in Moderna (MRNA) in Q2 2020: 15,108 shares worth $970K. The stake represents 0.02% of the portfolio and ranks #288 among its holdings.

489 funds tracked by Wall St. Rank hold MRNA as of Q2 2020.

  • Jupiter Investment Management held 15,108 shares of Moderna worth $970K as of Q2 2020.
  • Moderna was a new Jupiter Investment Management position in Q2 2020.
  • Moderna made up 0.02% of Jupiter Investment Management's portfolio in Q2 2020, its #288 holding.
  • 489 funds tracked by Wall St. Rank held Moderna as of Q2 2020.

Based on Jupiter Investment Management's 13F filing for Q2 2020, filed 13 Jul 2020.